Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 307

    1.

    Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects.

    Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M.

    Diabetes. 2005 Dec;54(12):3418-26.PMID: 16306357 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy.

    Gerhardinger C, Dagher Z, Sebastiani P, Park YS, Lorenzi M.

    Diabetes. 2009 Jul;58(7):1659-67. Epub 2009 Apr 28.PMID: 19401417 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

    Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS.

    Diabetes. 2007 Feb;56(2):337-45. Erratum in: Diabetes. 2007 May;56(5):1486. PMID: 17259377 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

    Kern TS, Engerman RL.

    Diabetes. 2001 Jul;50(7):1636-42.PMID: 11423486 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

    Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

    Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.

    Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M.

    Diabetes. 2006 Oct;55(10):2757-62.PMID: 17003340 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.

    De La Cruz P, Arrebola M, González-Correa A, Martinez-Cerdán E, Moreno A, de la Cuesta FS.

    Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):204-10. Epub 2003 Jan 9.PMID: 12595963 [PubMed - indexed for MEDLINE]Related articles

    9.

    Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.

    Int J Mol Med. 2008 Jun;21(6):667-76.PMID: 18506358 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

    Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42.PMID: 18235022 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.

    Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M.

    Diabetes. 2003 Feb;52(2):506-11.PMID: 12540628 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.

    Robison WG Jr, Tillis TN, Laver N, Kinoshita JH.

    Exp Eye Res. 1990 Apr;50(4):355-66.PMID: 2110907 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.

    De La Cruz P, Guerrero A, Paniego J, Arranz I, Moreno A, Sánchez De La Cuesta F.

    Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):96-101. Epub 2001 Dec 14.PMID: 11819026 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.

    Kowluru RA, Odenbach S.

    Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4161-6.PMID: 15505070 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.

    Gardiner TA, Anderson HR, Degenhardt T, Thorpe SR, Baynes JW, Archer DB, Stitt AW.

    Diabetologia. 2003 Sep;46(9):1269-75. Epub 2003 Jul 12.PMID: 12861449 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diabetes-induced vascular dysfunction in the retina: role of endothelins.

    Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S.

    Diabetologia. 1999 Oct;42(10):1228-34.PMID: 10525664 [PubMed - indexed for MEDLINE]Related articles

    18.

    Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes.

    Hammes HP, Federoff HJ, Brownlee M.

    Mol Med. 1995 Jul;1(5):527-34.PMID: 8529118 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats.

    Moreno A, De La Cruz JP, Mérida F, García Campos J, Sánchez de la Cuesta F.

    Haemostasis. 1995 Jul-Aug;25(4):166-71.PMID: 7557655 [PubMed - indexed for MEDLINE]Related articles

    20.

    Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.

    Hammes HP, Weiss A, Führer D, Krämer HJ, Papavassilis C, Grimminger F.

    Diabetologia. 1996 Mar;39(3):251-5.PMID: 8721768 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data